Results for tag: "Siliq"

The Siliq market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Siliq is a biologic drug used to treat moderate to severe plaque psoriasis, a chronic skin condition characterized by red, scaly patches on the skin. It is administered as a subcutaneous injection and works by blocking a protein in the body that causes inflammation. Siliq is one of several biologic drugs used to treat psoriasis, and is often used in combination with other treatments such as topical creams and light therapy. It is also used to treat other skin conditions such as atopic dermatitis and hidradenitis suppurativa. The Siliq market is highly competitive, with several major pharmaceutical companies offering similar treatments. Companies in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. Show Less Read more